Clinical Operations Journal by Dx Direct

Antibiotic Stewardship

Why Distinguishing Viral vs. Bacterial Infections Remains a Challenge in Urgent Care

Distinguishing between viral and bacterial infections remains one of the most common diagnostic challenges in primary care and urgent care settings. Patients frequently present with similar symptoms regardless of the underlying cause, making accurate diagnosis difficult during a single clinical encounter. This challenge is amplified by time constraints, patient expectations, and the limitations of symptom-based evaluation. Overlapping Clinical Symptoms Viral and bacterial infections often share the same clinical presentation, particularly in respiratory illnesses. Symptoms such as fever, cough, sore throat, fatigue, and body aches are common to both. In early

Read More »
Dx Direct

FDA Approved vs. FDA Cleared: Understanding the Key Difference You Need to Know

In recent years, advanced consumer technology has rapidly evolved to include health-monitoring features, from fitness trackers to wearable devices. As these products gain popularity, more and more tech companies are seeking FDA approval or clearance to market their devices. But here’s the catch: FDA approval and FDA clearance aren’t the same thing. Knowing the difference can be crucial to understanding the safety and effectiveness of the devices you’re using. Let’s break it down. What Does the FDA Do? The Food and Drug Administration (FDA) is responsible for ensuring that foods, drugs, and

Read More »

Simplifying Point-of-Care Adoption

Supporting better decisions without adding complexity.

FebriDx is intended to support clinical decision-making and must be interpreted in the context of signs, symptoms, patient history, and clinical judgment. It does not identify a specific pathogen and is not a standalone diagnostic.

FebriDx® is manufactured by Lumos Diagnostics. Dx Direct serves as an authorized distribution channel and does not manufacture the product.

© 2026. All Rights Reserved.